Megan Brooks
The Shingrix vaccine, a recombinant zoster vaccine, is widely used to prevent shingles (herpes zoster) in adults aged 50 and older. When billing for the administration of this vaccine, healthcare providers use Current Procedural Terminology (CPT) codes to ensure accurate reimbursement and documentation. The specific CPT code for the Shingrix vaccine administration is 90672, which covers the injection of the vaccine itself. Additionally, the vaccine product is billed separately using the appropriate Healthcare Common Procedure Coding System (HCPCS) code, typically G0325 for the first dose and G0326 for the second dose. Understanding these codes is essential for healthcare providers to streamline billing processes and ensure compliance with insurance requirements.
| Characteristics | Values |
|---|---|
| CPT Code | 90673 |
| Description | Vaccine, zoster (shingles), subunit, adjuvanted, for intramuscular use |
| Vaccine Name | Shingrix (Recombinant Zoster Vaccine) |
| Manufacturer | GlaxoSmithKline (GSK) |
| Administration Route | Intramuscular (IM) |
| Dose | 0.5 mL |
| Schedule | 2-dose series, 2-6 months apart |
| Age Indication | Adults aged 50 years and older |
| Billing | Separate CPT code for each dose |
| HCPCS Code | G0219 (Medicare-specific, used in addition to 90673 for administration) |
| ICD-10 Code | Z23 (Encounter for immunization) |
| Effective Date | January 1, 2018 (CPT code introduction) |
| Updates | No changes in recent years (as of October 2023) |
Explore related products
What You'll Learn
CPT Code for Shingrix Administration
The CPT code for administering the Shingrix vaccine is 90372, a critical identifier for healthcare providers and billing professionals. This code specifically refers to the injection of the recombinant zoster (shingle) vaccine, which is administered intramuscularly, typically in the deltoid muscle. Understanding this code is essential for accurate medical billing and reimbursement, ensuring that healthcare facilities and practitioners are compensated appropriately for their services.
Administration Process and Dosage
Shingrix is a two-dose vaccine, with the second dose given 2–6 months after the first. Each dose is 0.5 mL, and the vaccine is supplied in single-dose vials or prefilled syringes. The CPT code 90372 is reported for each dose administered, meaning two separate claims will be filed for the complete vaccination series. It’s crucial to document the date of each dose and ensure adherence to the recommended dosing interval to maximize the vaccine’s efficacy, which is approximately 90% in preventing shingles.
Billing Considerations
When billing for Shingrix administration, providers must include the appropriate diagnosis code, such as Z23 (encounter for immunization), alongside CPT code 90372. Additionally, the vaccine product itself is billed separately using HCPCS code G0319 for Medicare patients or NDC (National Drug Code) for other payers. Failure to use the correct codes can result in claim denials or delays in reimbursement. Always verify payer-specific guidelines, as some insurers may have unique requirements for billing Shingrix.
Practical Tips for Providers
To streamline the administration and billing process, ensure staff are trained on proper vaccine storage (Shingrix requires refrigeration at 2°C–8°C) and handling. Document the vaccine’s expiration date and lot number for each dose administered. For patients aged 50 and older, emphasize the importance of completing both doses, as partial vaccination provides significantly reduced protection. Finally, educate patients about potential side effects, such as arm pain, fatigue, or mild fever, which are common but typically resolve within 2–3 days.
Comparative Perspective
Unlike the older Zostavax vaccine, which used CPT code 90749, Shingrix’s code 90372 reflects its newer, recombinant technology and higher efficacy. While Zostavax was a live attenuated vaccine administered as a single dose, Shingrix’s two-dose regimen and non-live formulation make it suitable for a broader population, including immunocompromised individuals. This shift underscores the importance of staying updated on coding changes as medical advancements evolve.
Are Citi Bank and Axis Bank the Same? Key Differences Explained
You may want to see also
Explore related products
Shingrix Vaccine Billing Guidelines
The Shingrix vaccine, a critical tool in preventing shingles, requires precise billing to ensure proper reimbursement and compliance. The CPT code for Shingrix is 90673 for the first dose and 90674 for the second dose. These codes are essential for accurate billing, but they’re just the starting point. Understanding the nuances of Shingrix vaccine billing guidelines is crucial to avoid claim denials and ensure patients receive their vaccinations without financial barriers.
Dosage and Administration Details: Shingrix is administered in two doses, with the second dose given 2–6 months after the first. Each dose is 0.5 mL, injected intramuscularly, preferably in the deltoid muscle. Billing must reflect the correct CPT code for each dose, and the NDC (National Drug Code) for the vaccine should accompany the claim. For Medicare beneficiaries, the G0316 code is used for the first dose and G0317 for the second dose when billing under Part B. This distinction is vital, as incorrect coding can lead to delayed or denied payments.
Patient Eligibility and Coverage: Shingrix is recommended for adults aged 50 and older, regardless of whether they’ve had shingles or received the older Zostavax vaccine. Medicare Part D typically covers the vaccine, but if a patient is enrolled in a plan that doesn’t cover it, Medicare Part B may step in. Providers must verify coverage before administering the vaccine to avoid unexpected patient costs. For non-Medicare patients, private insurance plans often cover Shingrix, but prior authorization may be required. Always confirm eligibility and document it to streamline the billing process.
Common Pitfalls and Solutions: One frequent billing error is using the incorrect CPT code or failing to include the NDC. Another is billing both doses under the same claim, which can trigger denials. To avoid these issues, ensure each dose is billed separately with the appropriate code and NDC. Additionally, be aware of the incident-to billing rules if a non-physician administers the vaccine. Proper documentation, including the patient’s consent and medical necessity, is non-negotiable. Regularly updating staff on coding changes and payer-specific guidelines can prevent costly mistakes.
Practical Tips for Providers: Implement a checklist for Shingrix billing to ensure consistency. Train staff to verify patient eligibility and coverage before administration. Use electronic health records (EHR) to flag patients due for their second dose and automate reminders. For Medicare patients, confirm whether Part B coverage applies and use the appropriate G-codes. Finally, stay informed about updates from the CDC, CMS, and private payers, as guidelines can change. By mastering these specifics, providers can optimize Shingrix billing, improve patient care, and maintain financial health.
Accessing Your Bank Details in Stripe: A Step-by-Step Guide
You may want to see also
Explore related products
CPT Code 90673 Explained
CPT Code 90673 is the specific billing code used for administering the Shingrix vaccine, a critical tool in preventing shingles. This code is essential for healthcare providers and insurers to accurately process claims related to this vaccine. Understanding its nuances ensures proper reimbursement and compliance with medical billing standards.
What CPT Code 90673 Covers
This code specifically refers to the administration of the Shingrix vaccine, not the vaccine itself. It includes the act of injecting the vaccine, counseling the patient about its benefits and potential side effects, and documenting the procedure. The vaccine is typically given in two doses, 2 to 6 months apart, for individuals aged 50 and older. However, CPT Code 90673 is billed for each dose separately, meaning two administrations require two separate claims.
Key Differences from Other Vaccine Codes
Unlike CPT Code 90716, which is used for the Zostavax vaccine (an older shingles vaccine), 90673 is exclusive to Shingrix. This distinction is crucial because Shingrix is now the preferred vaccine due to its higher efficacy rate of over 90% in preventing shingles. Additionally, while some vaccine codes include the cost of the vaccine itself, 90673 only covers administration, requiring a separate code (e.g., HCPCS Code G0319) to bill for the vaccine product.
Practical Tips for Billing
When using CPT Code 90673, ensure the patient’s age and medical history align with Shingrix recommendations. Document the dose number (first or second) clearly in the medical record to avoid claim denials. Be aware that Medicare Part D, not Part B, typically covers the Shingrix vaccine, so billing processes may vary depending on the payer. Always verify the patient’s insurance coverage beforehand to prevent unexpected out-of-pocket costs.
Common Pitfalls to Avoid
A frequent mistake is bundling both doses under a single claim, which will result in rejection. Another error is using outdated codes or failing to include the appropriate vaccine product code alongside 90673. Stay updated on payer-specific guidelines, as some insurers may require additional modifiers or documentation. Proper training for billing staff on these specifics can save time and reduce claim rejections.
By mastering CPT Code 90673, healthcare providers can streamline the billing process for Shingrix vaccinations, ensuring patients receive this vital preventive care without administrative hurdles.
Buying Repossessed Boats: A Step-by-Step Guide to Bank Auctions
You may want to see also
Shingrix Coding for Medicare
The Shingrix vaccine, a critical tool in preventing shingles, requires precise coding for Medicare billing to ensure accurate reimbursement. The CPT code for the Shingrix vaccine itself is 90673, which covers the administration of the vaccine antigen. However, Medicare billing involves additional codes and considerations to account for the vaccine’s unique administration process and patient eligibility criteria. Understanding these nuances is essential for healthcare providers to navigate Medicare’s reimbursement system effectively.
Medicare Part D, not Part B, typically covers the Shingrix vaccine, which means it falls under the prescription drug benefit rather than the medical insurance benefit. This distinction is crucial because it affects how claims are processed and paid. Providers must ensure that the patient’s Part D plan covers the vaccine and that the claim is submitted through the appropriate pharmacy or medical billing channel. For patients without Part D coverage, alternative payment methods, such as cash payment or manufacturer assistance programs, may be necessary.
When administering Shingrix, providers must also bill for the vaccine administration using CPT code 90471 for the first dose and 90472 for the second dose. These codes account for the time, effort, and resources required to administer the vaccine, including patient counseling and monitoring. It’s important to note that Shingrix is a two-dose series, with the second dose administered 2–6 months after the first. Proper coding ensures that both doses are billed correctly and that the administration fees are reimbursed appropriately.
A common challenge in Shingrix coding for Medicare is ensuring patient eligibility. Medicare covers the Shingrix vaccine for adults aged 50 and older, but coverage may vary based on the Part D plan. Providers should verify the patient’s plan details before administration to avoid claim denials. Additionally, documenting the medical necessity of the vaccine, such as the patient’s age or risk factors for shingles, strengthens the claim and reduces the likelihood of audits or rejections.
Practical tips for successful Medicare billing include using the correct NDC (National Drug Code) for Shingrix, ensuring the patient’s Part D plan is active, and submitting claims electronically for faster processing. Providers should also stay updated on Medicare’s coding guidelines, as changes may occur annually. By mastering Shingrix coding for Medicare, healthcare providers can streamline their billing processes, maximize reimbursements, and ensure patients receive this vital vaccine without financial barriers.
Is Forte Reserve Bank in Turkey Legitimate? Uncovering the Truth
You may want to see also
Vaccine Administration Fees and CPT
The Shingrix vaccine, a critical tool in preventing shingles, is administered in two doses, typically 2 to 6 months apart. For healthcare providers, accurately billing for this service involves understanding the Current Procedural Terminology (CPT) codes associated with vaccine administration. The CPT code for administering the Shingrix vaccine is 90372 for the first dose and 90373 for the second dose. These codes specifically refer to the administration of zoster vaccine (Shingrix), recombinant, subunit, when used, and are distinct from codes for other vaccines or services.
Beyond the vaccine itself, providers must also consider the administration fee, which covers the cost of delivering the vaccine, including staff time, supplies, and overhead. This fee is billed separately using CPT code 90471 for the first dose and 90472 for the second dose. These codes account for the counseling, preparation, and administration of the vaccine, ensuring providers are compensated for the full scope of their services. It’s crucial to verify that both the vaccine product and administration codes are billed together to avoid claim denials.
A common pitfall in billing for Shingrix administration is failing to differentiate between the vaccine product and the administration service. For instance, the vaccine product is billed using HCPCS code G0315 for the first dose and G0316 for the second dose, while the administration is billed using the aforementioned CPT codes. Mixing these codes or omitting one can result in underpayment or rejection. Providers should also be aware of payer-specific guidelines, as some insurers may bundle administration fees or require prior authorization for patients under certain age groups, typically those over 50.
Practical tips for seamless billing include verifying patient eligibility for Shingrix before administration, as coverage varies by insurer and age group. For Medicare beneficiaries, the vaccine is covered under Part D, so providers should ensure the patient’s pharmacy benefit is active. Additionally, documenting the vaccine’s lot number, expiration date, and administration site (typically the deltoid muscle) is essential for compliance and record-keeping. Finally, staying updated on CPT code changes annually is critical, as revisions can impact billing accuracy and reimbursement rates.
In summary, mastering the CPT codes for Shingrix vaccine administration—90372 and 90373 for the vaccine, 90471 and 90472 for administration—is essential for accurate billing and reimbursement. By understanding the nuances of these codes, differentiating between product and service billing, and adhering to payer guidelines, providers can ensure they are fairly compensated while delivering this vital preventive care. Attention to detail in documentation and eligibility verification further streamlines the process, benefiting both the practice and the patient.
Does Jos A Bank Suit Include Tailoring? A Comprehensive Guide
You may want to see also
Frequently asked questions
The CPT code for the Shingrix vaccine (administration) is 90672.
No, CPT code 90672 only covers the administration of the Shingrix vaccine. The vaccine itself is billed separately using an HCPCS code, typically G0315.
No, the same CPT code 90672 is used for both the first and second doses of the Shingrix vaccine administration.
No, CPT code 90672 is specific to the administration of the Shingrix (recombinant zoster) vaccine and should not be used for other vaccines.
